Annual Book Value
-$157.96 M
-$251.58 M-268.72%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual book value is -$157.96 million, with the most recent change of -$251.58 million (-268.72%) on December 31, 2023.
- During the last 3 years, ACOR annual book value has fallen by -$395.91 million (-166.38%).
Performance
ACOR Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Book Value
-$208.11 M
-$50.16 M-31.75%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly book value is -$208.11 million, with the most recent change of -$50.16 million (-31.75%) on March 31, 2024.
- Over the past year, ACOR quarterly book value has dropped by -$285.07 million (-370.42%).
Performance
ACOR Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
ACOR Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -268.7% | -370.4% |
| 3 y3 years | -166.4% | -200.9% |
| 5 y5 years | -125.8% | -136.7% |
ACOR Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -204.5% | at low | -237.7% | at low |
| 5 y | 5-year | -150.8% | at low | -166.4% | at low |
| alltime | all time | -123.8% | at low | -130.2% | at low |
Acorda Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -$208.11 M(+31.8%) |
| Dec 2023 | -$157.96 M(-268.7%) | -$157.96 M(-367.9%) |
| Sep 2023 | - | $58.96 M(-13.1%) |
| Jun 2023 | - | $67.87 M(-11.8%) |
| Mar 2023 | - | $76.96 M(-17.8%) |
| Dec 2022 | $93.62 M(-38.1%) | $93.62 M(+23.6%) |
| Sep 2022 | - | $75.77 M(-13.8%) |
| Jun 2022 | - | $87.91 M(-31.1%) |
| Mar 2022 | - | $127.55 M(-15.6%) |
| Dec 2021 | $151.14 M(-36.5%) | $151.14 M(-8.1%) |
| Sep 2021 | - | $164.47 M(-13.7%) |
| Jun 2021 | - | $190.48 M(-7.7%) |
| Mar 2021 | - | $206.28 M(-13.3%) |
| Dec 2020 | $237.96 M(-23.4%) | $237.96 M(-24.1%) |
| Sep 2020 | - | $313.53 M(+7.8%) |
| Jun 2020 | - | $290.90 M(-5.1%) |
| Mar 2020 | - | $306.67 M(-1.3%) |
| Dec 2019 | $310.82 M(-49.2%) | $310.82 M(+10.5%) |
| Sep 2019 | - | $281.34 M(-48.4%) |
| Jun 2019 | - | $544.84 M(-3.8%) |
| Mar 2019 | - | $566.59 M(-7.4%) |
| Dec 2018 | $611.98 M(+17.7%) | $611.98 M(+2.2%) |
| Sep 2018 | - | $598.63 M(-1.3%) |
| Jun 2018 | - | $606.63 M(+10.3%) |
| Mar 2018 | - | $549.92 M(+5.8%) |
| Dec 2017 | $519.99 M(-21.7%) | $519.99 M(-23.5%) |
| Sep 2017 | - | $679.99 M(-1.4%) |
| Jun 2017 | - | $689.72 M(+2.0%) |
| Mar 2017 | - | $676.13 M(+1.8%) |
| Dec 2016 | $664.21 M(+10.1%) | $664.21 M(-0.4%) |
| Sep 2016 | - | $666.77 M(-0.7%) |
| Jun 2016 | - | $671.64 M(-1.8%) |
| Mar 2016 | - | $684.01 M(+13.4%) |
| Dec 2015 | $603.02 M(+11.6%) | $603.02 M(+4.9%) |
| Sep 2015 | - | $574.89 M(+2.6%) |
| Jun 2015 | - | $560.28 M(+2.1%) |
| Mar 2015 | - | $549.02 M(+1.6%) |
| Dec 2014 | $540.25 M | $540.25 M(+3.3%) |
| Sep 2014 | - | $522.91 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $500.38 M(+11.1%) |
| Mar 2014 | - | $450.52 M(+2.3%) |
| Dec 2013 | $440.35 M(+14.1%) | $440.35 M(+3.3%) |
| Sep 2013 | - | $426.39 M(+5.3%) |
| Jun 2013 | - | $404.80 M(+3.4%) |
| Mar 2013 | - | $391.64 M(+1.5%) |
| Dec 2012 | $385.92 M(+88.1%) | $385.92 M(+57.2%) |
| Sep 2012 | - | $245.47 M(+6.9%) |
| Jun 2012 | - | $229.65 M(+4.8%) |
| Mar 2012 | - | $219.09 M(+6.8%) |
| Dec 2011 | $205.21 M(+35.7%) | $205.21 M(+9.8%) |
| Sep 2011 | - | $186.92 M(+14.8%) |
| Jun 2011 | - | $162.75 M(+5.1%) |
| Mar 2011 | - | $154.79 M(+2.3%) |
| Dec 2010 | $151.26 M(+10.1%) | $151.26 M(+6.3%) |
| Sep 2010 | - | $142.36 M(+16.0%) |
| Jun 2010 | - | $122.70 M(-0.6%) |
| Mar 2010 | - | $123.45 M(-10.1%) |
| Dec 2009 | $137.33 M(-33.7%) | $137.33 M(-12.1%) |
| Sep 2009 | - | $156.28 M(-9.0%) |
| Jun 2009 | - | $171.80 M(-10.3%) |
| Mar 2009 | - | $191.49 M(-7.6%) |
| Dec 2008 | $207.16 M(+226.6%) | $207.16 M(-7.7%) |
| Sep 2008 | - | $224.34 M(+99.6%) |
| Jun 2008 | - | $112.41 M(-11.3%) |
| Mar 2008 | - | $126.70 M(+99.7%) |
| Dec 2007 | $63.43 M(+239.8%) | $63.43 M(-15.4%) |
| Sep 2007 | - | $75.02 M(+6.1%) |
| Jun 2007 | - | $70.68 M(+420.1%) |
| Mar 2007 | - | $13.59 M(-27.2%) |
| Dec 2006 | $18.67 M(-116.0%) | $18.67 M(-322.4%) |
| Sep 2006 | - | -$8.39 M(+281.8%) |
| Jun 2006 | - | -$2.20 M(+677.7%) |
| Mar 2006 | - | -$282.70 K(-99.8%) |
| Dec 2005 | -$116.54 M(+92.4%) | -$116.54 M(+14.6%) |
| Sep 2005 | - | -$101.68 M(-681.6%) |
| Dec 2004 | -$60.58 M(>+9900.0%) | - |
| Dec 2003 | -$130.00 K(-100.4%) | - |
| Sep 2003 | - | $17.48 M |
| Jun 2003 | $35.33 M | - |
FAQ
- What is Acorda Therapeutics annual book value?
- What is the all time high annual book value for Acorda Therapeutics?
- What is Acorda Therapeutics annual book value year-on-year change?
- What is Acorda Therapeutics quarterly book value?
- What is the all time high quarterly book value for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly book value year-on-year change?
What is Acorda Therapeutics annual book value?
The current annual book value of ACOR is -$157.96 M
What is the all time high annual book value for Acorda Therapeutics?
Acorda Therapeutics all-time high annual book value is $664.21 M
What is Acorda Therapeutics annual book value year-on-year change?
Over the past year, ACOR annual book value has changed by -$251.58 M (-268.72%)
What is Acorda Therapeutics quarterly book value?
The current quarterly book value of ACOR is -$208.11 M
What is the all time high quarterly book value for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly book value is $689.72 M
What is Acorda Therapeutics quarterly book value year-on-year change?
Over the past year, ACOR quarterly book value has changed by -$285.07 M (-370.42%)